CERo Therapeutics Holdings, Inc.
CERO
$0.8899
-$0.0579-6.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.30M | -10.24M | -7.51M | -7.15M | -7.29M |
| Total Depreciation and Amortization | 1.16M | 1.16M | 1.15M | 1.13M | 1.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.61M | -3.73M | -4.12M | -2.39M | -157.70K |
| Change in Net Operating Assets | 1.84M | 468.60K | -416.60K | -1.03M | 540.20K |
| Cash from Operations | -12.92M | -12.34M | -10.90M | -9.43M | -5.79M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -13.82M | -8.13M | -7.84M | -7.94M |
| Total Debt Issued | 421.80K | 408.10K | 408.10K | 1.01M | 605.20K |
| Total Debt Repaid | -422.20K | -278.70K | -169.00K | -19.70K | 0.00 |
| Issuance of Common Stock | 5.31M | 5.31M | 2.74M | 18.10K | 9.60K |
| Repurchase of Common Stock | -500.80K | -- | -1.90K | -1.90K | -1.90K |
| Issuance of Preferred Stock | 9.49M | 9.49M | 6.76M | 6.76M | -- |
| Repurchase of Preferred Stock | -45.90K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -528.20K | -2.69M | 13.70K | -41.20K | -41.20K |
| Cash from Financing | 13.73M | 12.24M | 9.75M | 7.72M | 571.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 811.70K | -96.00K | -1.15M | -1.71M | -5.22M |